Healthcare decisions are intensely personal, and everyone deserves the right to make their own healthcare decisions and from what type of healthcare coverage they purchase to what medications they take. Health reform that works must be focused on expanding choices including allowing individuals to purchase insurance across state lines, to opt for an alternative to traditional health insurance, and to allow individual patients to access promising medications.
- Press Releases
- In the News
- OpEds & Blogs
FOR IMMEDIATE RELEASE: COLORADO TO BECOME FIRST IN NATION TO GIVE DYING PATIENTS’ ‘RIGHT TO TRY’ LIFE-SAVING EXPERIMENTAL MEDICINESPosted on May 15, 2014 | Type: Press Release
Fort, Collins, CO-- Colorado is poised to become the first state in the nation to allow terminally ill patients to access safe experimental medications that could save their lives, even when those medicines are years away from hitting the market. Governor John Hickenlooper (D) is expected to sign the nation’s first Right to Try Act Saturday in a ceremony with patients and advocates at a Fort Collins-area hospital.
Coons v. Lew (IPAB/federal health care lawsuit)Posted on May 12, 2014 | Type: Case
On August 12, 2010 the Goldwater Institute filed a lawsuit against the Affordable Care Act, challenging the constitutionality of the rationing board IPAB and the individual mandate.
FOR IMMEDIATE RELEASE: AZ VOTERS TO DETERMINE TERMINAL PATIENTS’ RIGHTSPosted on April 16, 2014 | Type: Press Release
Right to Try bill passes AZ legislature, goes on November ballot for voter approval
STATE LAWMAKERS IN THREE STATES VOTE UNANIMOUSLY TO ALLOW TERMINAL PATIENTS EXPERIMENTAL DRUG ACCESS, CUT FDA RED TAPEPosted on April 02, 2014 | Type: Press Release
State representatives in Colorado, Louisiana and Missouri all voted unanimously this week to approve an unprecedented measure to empower terminally ill patients to access experimental drugs that could save their lives but have not yet been approved for market by the FDA.
FOR IMMEDIATE RELEASE: MO LAWMAKERS TO GREEN-LIGHT “RIGHT TO TRY” LIFE-SAVING MEDICATIONS BILL WEDNESDAYPosted on February 26, 2014 | Type: Press Release
The reform, known as the “Right to Try” Act, would empower terminally ill patients under the care of licensed doctors to access experimental drugs that have passed basic safety tests but whose efficacy is not yet conclusive. Currently, it takes nearly a decade and up to $1 billion to shepherd life-saving treatments through the FDA approval process—time the sickest Americans simply do not have to wait.